...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cardiac surgery. >Reoperation for composite valve graft failure: Operative results and midterm survival
【24h】

Reoperation for composite valve graft failure: Operative results and midterm survival

机译：复合阀移植失效的重新组合：手术结果和中期存活

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Abstract Background and Aim of the Study The replacement of a failed composite valve graft is technically more demanding and is associated with increased morbidity and mortality. We present our technique and outcomes for reoperations for composite graft failures. Methods Between September 2011 and June 2017, 14 patients underwent a redo composite graft replacement. Twelve patients (85.7%) were male, and mean age was 58.4 years?±?12 standard deviation (SD). One patient had two previous root replacements. Indications for reoperation were endocarditis (8), aortic pseudoaneurysm (3), and aortic prosthesis thrombosis (3). Mean logistic EuroSCORE and EuroSCORE II were 30.8% and 14.7%, respectively. Results A mechanical composite graft was used in 12 patients and biological composite grafts were used in two patients. Hospital mortality was 14.3% ( n ?=?2). One patient (7.1%) required reoperation for bleeding, One patient (7.1%) had mechanical ventilation 24?h, and four patients (28.6%) required implantation of a permanent pacemaker. Median intensive care unit and hospital stays were 3 days (interquartile range [IQR] 1‐5) and 10 days (IQR 6.5‐38.5). One patient experienced recurrent prosthetic valve endocarditis 14 months after operation. On follow‐up, 11 of 12 survivors were in New York Heart Association class I or II. Survival at 3 years was 85.7%?±?9.4% SD. Conclusions Composite valve graft replacement can be performed with acceptable morbidity and mortality with good mid‐term survival.
机译：摘要研究背景和目的：替换失败的复合瓣膜移植在技术上要求更高，并且与发病率和死亡率增加有关。我们介绍了复合移植失败再手术的技术和结果。方法在2011年9月至2017年6月期间，14名患者接受了重做复合移植物置换术。12名患者（85.7%）为男性，平均年龄为58.4岁？±?12标准偏差（SD）。一名患者曾进行过两次牙根置换。再次手术指征为心内膜炎（8例）、主动脉假性动脉瘤（3例）和主动脉假体血栓（3例）。平均逻辑欧洲评分和欧洲评分II分别为30.8%和14.7%。结果12例采用机械复合移植，2例采用生物复合移植。医院死亡率为14.3%（n=2）。1名患者（7.1%）因出血需要再次手术，1名患者（7.1%）接受机械通气；24?h、 4名患者（28.6%）需要植入永久性起搏器。中位重症监护病房和住院时间分别为3天（四分位间距[IQR]1-5）和10天（IQR 6.5-38.5）。1例患者术后14个月出现复发性人工瓣膜心内膜炎。在随访中，12名幸存者中有11人属于纽约心脏协会一级或二级。3年生存率为85.7%？±?标准差9.4%。结论复合瓣膜置换术具有可接受的发病率和死亡率以及良好的中期生存率。

著录项

  • 来源
    《Journal of cardiac surgery.》 |2018年第6期|共7页
  • 作者

    Maroto Luis C.; Carnero Manuel; Cobiella Javier; García Mónica; Vilacosta Isidre; Reguillo Fernando; Villagrán Enrique; Olmos Carmen;

  • 作者单位

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiology Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiac Surgery Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

    Department of Cardiology Cardiovascular InstituteClínico San Carlos HospitalMadrid Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏血管和淋巴系外科学;
  • 关键词

    aorta; great vessels; reoperation;

    机译：主动脉;伟大的船只;重新开始;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号